OR WAIT null SECS
April 02, 2019
It is important to address manufacturing problems associated with the shorter shelf-life of pegylated L-asparaginase (pegaspargase) upon long-term storage in the form of a solution.
Easier access to information, targeting smaller patient populations, and increased regulatory focus on patient outcomes are driving patient‑centric drug development.
April 01, 2019
Market demand and regulatory guidance continues to promote improved medication design.
Laboratory testing found that a novel approach reduced the time required for sample preparation from hours to minutes. This article summarizes test methods and results.
Modified-release oral dosage forms can offer benefits to both formulation scientists and patients.
March 01, 2019
The technology uses a silica nanoparticle to deliver vaccines and cancer treatments.
February 15, 2019
The drug is approved in the United States specifically for treating acquired thrombotic thrombocytopenic purpura, a rare blood-clotting disorder.
February 07, 2019
Researchers used magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus.
February 02, 2019
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.